Age-dependent systemic DNA damage in early Type 2 Diabetes mellitus

  • Dinko Rogulj Brežice general hospital 8250 Brežice Slovenia
  • Ismail El Aklouk General hospital Varaždin department for prolonged treatment
  • Konjevoda Paško NMR Center Ruđer Bošković Institute
  • Spomenka Ljubić Vuk Vrhovac University Clinic for Diabetes, Endocrinology and Metabolic Diseases, University Hospital Merkur, Zagreb, Croatia
  • Mirjana Pibernik Okanović University Clinic for Diabetes, Endocrinology and Metabolic Diseases, University Hospital Merkur, Zagreb, Croatia
  • Ante Barbir
  • Marijana Luburić Polyclynic Sunce, Zagreb, Croatia
  • Maja Radman Department of Internal Medicine, University Hospital Centre Split, Split, Croatia
  • Ninoslav Budinski Department of Internal Medicine, University Hospital Sveti Duh, Zagreb, Croatia
  • Marijana Vučić Lovrenčić 8Department of Clinical Chemistry and Laboratory Medicine, University Hospital Merkur, Zagreb, Croatia
Keywords: metabolic syndrome, type 2 diabetes mellitus, DNA damage, urinary 8-oxodG


Oxidative stress, capable of eliciting damage to various biomolecules including DNA, is a recognized component of diabetes mellitus and its complications. Metabolic syndrome  (MetS) is associated with the development of type 2 diabetes mellitus  (T2DM), as well as other unfavorable outcomes. The aim of this study was to elucidate the role of oxidative stress in the development of T2DM, by investigating association of oxidative DNA damage with metabolic parameters in subjects with MetS and early T2DM.

Selected anthropometric and biochemical parameters of MetS, inflammation and oxidative DNA damage: body mass index  (BMI), fatty liver index  (FLI), waist circumference  (WC), total cholesterol, HDL  and LDL-cholesterol, GGT, uric acid, total leukocyte/neutrophil count,  and urinary 8-oxo-deoxyguanosine  (u-8-oxodG) were assessed in male subjects with MetS and both younger  (≤55 years) and older  (>55 years) subjects with T2DM of short duration without complications.

BMI, FLI, WC, total and LDL-cholesterol and  uric acid were higher, while the u-8-oxodG was lower in MetS group, when compared to older T2DM subjects. None of these parameters were different neither between MetS and younger T2DM, nor between two sub-groups of subjects with T2DM. Values of CRP, HDL-cholesterol, triglycerides, GGT, leukocytes and neutrophils were not different between all examined groups of subjects.

Age-dependent increase in u-8-oxodG suggests that aging process, rather than metabolic disturbances or diabetes per se plays a pivotal role in development of oxidative DNA-damage in T2DM. Oxidative DNA damage cannot serve as an universal early marker of T2DM.

Author Biography

Dinko Rogulj, Brežice general hospital 8250 Brežice Slovenia
Internal medicine


Roberts CK, Sindhu KK (2009) Oxidative stress and metabolic syndrome. Life Sci 84: 705–712.

Rochette L, Zeller M, Cottin Y, Vergely C (2014) Diabetes, oxidative stress and therapeutic strategies. Bioch Biophys Acta 1840: 2709–2729.

Valko M, Leibfritz D, Moncol J, Cronin TDM, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39: 44–84.

Halliwell B, Gutteridge JMC (2015) Reactive species can be poisonous. In Free Radical Biology and Medicine. 5th ed. Halliwell B, Gutteridge JMC eds, pp 463–510. Oxford University Press.

Erol A (2010) Systemic DNA damage response and metabolic syndrome as a premalignant state. Curr Mol Med 10: 321-334.

Jackson SP, Bartek J (2009) The DNA-damage response in human biology and disease. Nature 461: 1071–1078.

Poulsen HE, Nadal LL, Broedbaek K, Nielsen PE, Weimann A (2014) Detection and interpretation of 8-oxodG and 8-oxoGua in urine, plasma and cerebrospinal fluid. Biochim Biophys Acta 1840: 801–808.

Loft S, Danielsen P, Løhr M, Jantzen K, Hemmingsen JG, Roursgaard M, Karotki DG, Møller P (2012) Urinary excretion of 8-oxo-7,8-dihydroguanine as biomarker of oxidative damage to DNA. Arch Bioc-hem Biophys 518: 142-150.

Demirbag R, Yilmaz R, Gur M, Celik H, Guzel S, Selek S Kocyigit A (2006) DNA damage in metabolic syndrome and its association with antioxidative and oxidative measurements Int J Clin Pract 60: 1187-1193.

Song F, Jia W, Yao Y (2007) Oxidative stress, antioxidant status and DNA damage in patients with im-paired glucose regulation and newly diagnosed Type 2 diabetes Clin Sci (Lond) 112: 599-606.

Milić M, Kišan M, Rogulj D, Radman M, Lovrenčić MV, Konjevoda P, Domijan AM (2013) Level of primary DNA damage in the early stage of metabolic syndrome. Mutat Res Genet Toxicol Environ Mu-tagen 758: 1-5.

Broedbaek K, Weimann A, Stovgaard ES, Poulsen HE (2011) Urinary 8-oxo-7,8-dihydro-2’-deoxyguanosine as a biomarker in type 2 diabetes. Free Radic Biol Med 51: 1473–1479.

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285: 2486-2497.

Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C et (2006) The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 6: 33.

Evans MD, Singh R, Mistry V, Sandhu K, Farmer PB, Cooke MS (2008) Analysis of urinary 8-oxo-7,8-dihydro-purine-2'-deoxyribonucleosides by LC-MS/MS and improved ELISA. Free Radic Res 42: 831-840.

Soares JP, Cortinhas A, Bento T, Leitão JC, Collins AR, Gaivão I, Mota MP (2014) Aging and DNA damage in humans: a meta‐analysis study. Aging (Albany NY) 6: 432-439.

Blasiak J, Arabski M, Krupa R, Wozniak K, Zadrozny M, Kasznicki J, Zurawska M, Drzewoski J (2004) DNA damage and repair in type 2 diabetes mellitus. Mutat Res; 554: 297-304.

Bukhari SA, Naqvi SA, Nagra SA, Anjum F, Javed S, Farooq M (2015) Assessing of oxidative stress rela-ted parameters. Pak J Pharm Sci 28: 483-491.

Løhr M, Jensen A, Eriksen L, Grønbæk M, Loft S, Møller P (2015). Age and metabolic risk factors associated with oxidatively damaged DNA in human peripheral blood mononuclear cells. Oncotarget 6: 2641-2653.

International Diabetes Federation (2015). IDF Diabetes Atlas. 7 ed. International Diabetes federation.

Feig D, Duk-Hee K, Johnson RH (2008) Uric Acid and Cardiovascular Risk. N Engl J Med 359: 1811-1821.

Takahashi S, Yamamoto T, Tsutsumi Z, Moriwaki Y, Yamakita J, Higashino K (1997) Close correlation between visceral fat accumulation and uric acid metabolism in healthy men. Metabolism 46: 1162-1165.

Hayden MR, Tyagi SC (2004) Uric acid: A new look at an old risk marker for cardiovascular disease me-tabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Nutr Metab (Lond) 1: 10.

Bashan N, Kovsan J, Kachko I, Ovadia H, Rudich A (2009) Positive and negative regulation of insulin sig-naling by reactive oxygen and nitrogen species. Physiol Rev 89: 27-71.

Vučić Lovrenčić M, Pibernik-Okanović M, Šekerija M, Prašek M, Ajduković D, Kos J, Hermanns N (2015) Improvement in Depressive Symptoms Is Associated with Reduced Oxidative Damage and Inflammatory Response in Type 2 Diabetic Patients with Subsyndromal Depression: The Results of a Randomized Controlled Trial Comparing Psychoeducation, Physical Exercise, and Enhanced Treatment as Usual. J Endocrinol Diabetes 210406.

Hanigan MH (2014) Gamma-glutamyl transpeptidase: redox regulation and drug resistance. Adv Cancer Res 122: 103–141.

Al Aubaidy H, Jelinek HF (2011) Oxidative DNA damage and obesity in type 2 diabetes mellitus. Eur J Endocrinol 164: 899-904.

Rytter E, Vessby B, Asgård R, Johansson C, Sjödin A, Abramsson-Zetterberg L, Möller L, Basu S (2009) Glycaemic status in relation to oxidative stress and inflammation in well-controlled type 2 diabetes sub-jects. Br J Nutr 101: 1423-1426.

Dincer Y, Akcay T, Alademir Z, Seyisoglu H, Ertungalp E (2002). Assessment of DNA base oxidation and glutathione level in patients with type 2 diabetes. Mutat Res 505: 75–81.